A call to action to harmonize patient-reported outcomes evidence requirements across key European HTA bodies in oncology.
Sign Up to like & getrecommendations! Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2022-0374
Abstract: Patient-reported outcome (PRO) data are increasingly being included in Health Technology Assessment (HTA) submissions for oncology drugs. This study aims to provide differences in PRO evidence requirements in oncology across key HTA bodies and calls… read more here.
Keywords: evidence requirements; oncology; across key; patient reported ... See more keywords